Characterization of Ovastacin and ZP2 Antibodies
Corresponding Organization : National Institute of Diabetes and Digestive and Kidney Diseases
Variable analysis
- Rabbit polyclonal antibody that binds a C-terminal peptide of ovastacin
- Monoclonal antibody M2c.2 that binds to the C-terminal region of ZP2
- Not explicitly mentioned
- LCA-FITC (Sigma-Aldrich)
- Antibodies to GP73, calregulin and EEA1
- Alexa Fluor 488 goat anti-rabbit IgG (H+L) (Life Technologies-Invitrogen, Carlsbad, CA)
- Alexa Fluor 555 donkey anti-rabbit IgG (H+L) (Life Technologies-Invitrogen)
- DyLight 649 goat anti–rabbit IgG (H+L) (Life Technologies-Invitrogen)
- Goat anti-rat IgG-HRP (Santa Cruz)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!